Chemomab Therapeutics (CMMB) EPS (Basic) (2020 - 2026)
Chemomab Therapeutics' EPS (Basic) was $0.34 in Q2 2026, down 25.9% from $0.46 a year earlier.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) EPS (Basic) (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Chemomab Therapeutics' EPS (Basic) was $0.63 through Jun 30, 2026, down 45.6% year-over-year; for FY2025, it was $1.41, down 54.6% from FY2024.
- EPS (Basic) has now declined for three consecutive years.
- In earlier years, EPS (Basic) was $3.11 in FY2024 (-62.3%), $8.25 in FY2023 (-15.2%), $9.72 in FY2022 (+102.0%) and $4.81 in FY2021.
- Quarterly EPS (Basic) has moved between -$3.17 (Q1 2023) and $7.68 (Q4 2021) over five years.
- The best year-over-year quarter for EPS (Basic) over five years was Q2 2023 (growth of 32.9%); the worst was Q3 2025 (a decline of 67.3%).
- Per Business Quant data, CMMB's EPS (Basic) in the three quarters before Q2 2026 was -$0.28 (Q1 2026), $0.29 (Q4 2025) and $0.39 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 2.30 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 1.68 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 1.87 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.40 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -0.04 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 4.34 |
| 10 | Chemomab Therapeutics | 11.80 Mn | 11.80 Mn | - | 0.34 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.34 |
| Mar 31, 2026 | -0.28 |
| Dec 31, 2025 | 0.29 |
| Sep 30, 2025 | 0.39 |
| Jun 30, 2025 | 0.46 |
| Mar 31, 2025 | -0.74 |
| Dec 31, 2024 | 0.66 |
| Sep 30, 2024 | 1.19 |
| Jun 30, 2024 | -1.24 |
| Mar 31, 2024 | -1.32 |
| Dec 31, 2023 | 1.16 |
| Sep 30, 2023 | 1.48 |
| Jun 30, 2023 | 2.89 |
| Mar 31, 2023 | -3.17 |
| Dec 31, 2022 | 2.91 |
| Sep 30, 2022 | 2.83 |
| Jun 30, 2022 | 2.17 |
| Mar 31, 2022 | -1.79 |
| Dec 31, 2021 | 7.68 |
| Sep 30, 2021 | -1.04 |
API Access
Chemomab Therapeutics EPS (Basic) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-basic&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-basic", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-basic&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();